As it turns out, featherweight Diego Brandao (pictured) and Nick Diaz would get along very well outside the cage. On Friday, the U.S. Anti-Doping Agency (USADA) notified the UFC that Brandao tested positive for marijuana metabolites following his UFC 195 loss to Brian Ortega.
“The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) informed Diego Brandao of a potential Anti-Doping Policy violation involving Carboxy-Tetrahydrocannabinol (“Carboxy-THC”) which is a metabolite of marijuana and/or hashish, above the decision limit of 180 ng/mL, stemming from an in-competition sample collected following his fight on January 2, 2016 in Las Vegas,” the UFC expressed in a statement.
“USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Brandao, as it relates to the UFC Anti-Doping Policy and future UFC participation. Because the Nevada State Athletic Commission was the regulatory body overseeing the fight in Las Vegas and has state licensing and jurisdiction over Brandao, USADA will work to ensure that the Commission has the necessary information to determine its proper judgment of Brandao’s potential anti-doping violation. Additional information will be provided at the appropriate time as the process moves forward.”
Brandao becomes the second UFC fighter to flunk at drug test this week. Middleweight top contender Yoel Romero is likely in deeper water, though.
Brandao is facing a fine and suspension.
Brandao, 28, appeared well on his way to beating Ortega, but Ortega had Brandao right where he wanted him by extending Brandao into the third round. Knowing Brandao’s pace slows significantly beyond the opening period, Ortega managed to take advantage and slap on a triangle choke to complete the comeback in the January 2 contest.